Eintrag weiter verarbeiten

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: Journal for ImmunoTherapy of Cancer
Personen und Körperschaften: Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S
In: Journal for ImmunoTherapy of Cancer, 3, 2015, S2
Format: E-Article
Sprache: Englisch
veröffentlicht:
BMJ
Schlagwörter:
author_facet Morishima, Chihiro
McNeel, Douglas G
Patel, Manish R
Kohrt, Holbrook E
Waldmann, Thomas A
Thompson, John A
Conlon, Kevin C
Sondel, Paul M
Wakelee, Heather A
Apodaca, Minjun C
Fling, Steven P
Disis, Mary L
Creekmore, Stephen P
Miller, Jeffrey S
Morishima, Chihiro
McNeel, Douglas G
Patel, Manish R
Kohrt, Holbrook E
Waldmann, Thomas A
Thompson, John A
Conlon, Kevin C
Sondel, Paul M
Wakelee, Heather A
Apodaca, Minjun C
Fling, Steven P
Disis, Mary L
Creekmore, Stephen P
Miller, Jeffrey S
author Morishima, Chihiro
McNeel, Douglas G
Patel, Manish R
Kohrt, Holbrook E
Waldmann, Thomas A
Thompson, John A
Conlon, Kevin C
Sondel, Paul M
Wakelee, Heather A
Apodaca, Minjun C
Fling, Steven P
Disis, Mary L
Creekmore, Stephen P
Miller, Jeffrey S
spellingShingle Morishima, Chihiro
McNeel, Douglas G
Patel, Manish R
Kohrt, Holbrook E
Waldmann, Thomas A
Thompson, John A
Conlon, Kevin C
Sondel, Paul M
Wakelee, Heather A
Apodaca, Minjun C
Fling, Steven P
Disis, Mary L
Creekmore, Stephen P
Miller, Jeffrey S
Journal for ImmunoTherapy of Cancer
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
Cancer Research
Pharmacology
Oncology
Molecular Medicine
Immunology
Immunology and Allergy
author_sort morishima, chihiro
spelling Morishima, Chihiro McNeel, Douglas G Patel, Manish R Kohrt, Holbrook E Waldmann, Thomas A Thompson, John A Conlon, Kevin C Sondel, Paul M Wakelee, Heather A Apodaca, Minjun C Fling, Steven P Disis, Mary L Creekmore, Stephen P Miller, Jeffrey S 2051-1426 BMJ Cancer Research Pharmacology Oncology Molecular Medicine Immunology Immunology and Allergy http://dx.doi.org/10.1186/2051-1426-3-s2-p203 CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells Journal for ImmunoTherapy of Cancer
doi_str_mv 10.1186/2051-1426-3-s2-p203
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8yMDUxLTE0MjYtMy1zMi1wMjAz
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8yMDUxLTE0MjYtMy1zMi1wMjAz
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint BMJ, 2015
imprint_str_mv BMJ, 2015
issn 2051-1426
issn_str_mv 2051-1426
language English
mega_collection BMJ (CrossRef)
match_str morishima2015citn1102interimtrialresultssubcutaneousadministrationofrecombinanthumanil15rhil15isassociatedwithexpansionofperipheralbloodcd56nkcellsandcd8tcells
publishDateSort 2015
publisher BMJ
recordtype ai
record_format ai
series Journal for ImmunoTherapy of Cancer
source_id 49
title CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_unstemmed CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_full CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_fullStr CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_full_unstemmed CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_short CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_sort citn11-02 interim trial results: subcutaneous administration of recombinant human il-15 (rhil-15) is associated with expansion of peripheral blood cd56+ nk cells and cd8+ t cells
topic Cancer Research
Pharmacology
Oncology
Molecular Medicine
Immunology
Immunology and Allergy
url http://dx.doi.org/10.1186/2051-1426-3-s2-p203
publishDate 2015
physical
description
container_issue S2
container_start_page 0
container_title Journal for ImmunoTherapy of Cancer
container_volume 3
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792326729756311558
geogr_code not assigned
last_indexed 2024-03-01T12:25:33.29Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=CITN11-02+interim+trial+results%3A+subcutaneous+administration+of+recombinant+human+IL-15+%28rhIL-15%29+is+associated+with+expansion+of+peripheral+blood+CD56%2B+NK+cells+and+CD8%2B+T+cells&rft.date=2015-12-01&genre=article&issn=2051-1426&volume=3&issue=S2&jtitle=Journal+for+ImmunoTherapy+of+Cancer&atitle=CITN11-02+interim+trial+results%3A+subcutaneous+administration+of+recombinant+human+IL-15+%28rhIL-15%29+is+associated+with+expansion+of+peripheral+blood+CD56%2B+NK+cells+and+CD8%2B+T+cells&aulast=Miller&aufirst=Jeffrey+S&rft_id=info%3Adoi%2F10.1186%2F2051-1426-3-s2-p203&rft.language%5B0%5D=eng
SOLR
_version_ 1792326729756311558
author Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S
author_facet Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S, Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S
author_sort morishima, chihiro
container_issue S2
container_start_page 0
container_title Journal for ImmunoTherapy of Cancer
container_volume 3
description
doi_str_mv 10.1186/2051-1426-3-s2-p203
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie, Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8yMDUxLTE0MjYtMy1zMi1wMjAz
imprint BMJ, 2015
imprint_str_mv BMJ, 2015
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 2051-1426
issn_str_mv 2051-1426
language English
last_indexed 2024-03-01T12:25:33.29Z
match_str morishima2015citn1102interimtrialresultssubcutaneousadministrationofrecombinanthumanil15rhil15isassociatedwithexpansionofperipheralbloodcd56nkcellsandcd8tcells
mega_collection BMJ (CrossRef)
physical
publishDate 2015
publishDateSort 2015
publisher BMJ
record_format ai
recordtype ai
series Journal for ImmunoTherapy of Cancer
source_id 49
spelling Morishima, Chihiro McNeel, Douglas G Patel, Manish R Kohrt, Holbrook E Waldmann, Thomas A Thompson, John A Conlon, Kevin C Sondel, Paul M Wakelee, Heather A Apodaca, Minjun C Fling, Steven P Disis, Mary L Creekmore, Stephen P Miller, Jeffrey S 2051-1426 BMJ Cancer Research Pharmacology Oncology Molecular Medicine Immunology Immunology and Allergy http://dx.doi.org/10.1186/2051-1426-3-s2-p203 CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells Journal for ImmunoTherapy of Cancer
spellingShingle Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook E, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin C, Sondel, Paul M, Wakelee, Heather A, Apodaca, Minjun C, Fling, Steven P, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S, Journal for ImmunoTherapy of Cancer, CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells, Cancer Research, Pharmacology, Oncology, Molecular Medicine, Immunology, Immunology and Allergy
title CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_full CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_fullStr CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_full_unstemmed CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_short CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
title_sort citn11-02 interim trial results: subcutaneous administration of recombinant human il-15 (rhil-15) is associated with expansion of peripheral blood cd56+ nk cells and cd8+ t cells
title_unstemmed CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
topic Cancer Research, Pharmacology, Oncology, Molecular Medicine, Immunology, Immunology and Allergy
url http://dx.doi.org/10.1186/2051-1426-3-s2-p203